Viewing Study NCT04983095


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-01-29 @ 5:05 AM
Study NCT ID: NCT04983095
Status: RECRUITING
Last Update Posted: 2024-11-22
First Post: 2021-06-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
Sponsor: Karin Soderkvist
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: METRO_vers1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None OTHER View